The global market for Chronic Obstructive Pulmonary Disease Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Chronic Obstructive Pulmonary Disease Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Obstructive Pulmonary Disease Treatment Drug.

The Chronic Obstructive Pulmonary Disease Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Obstructive Pulmonary Disease Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Obstructive Pulmonary Disease Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Obstructive Pulmonary Disease Treatment Drug Market Report

Report Metric	Details
Report Name	Chronic Obstructive Pulmonary Disease Treatment Drug Market
CAGR	5%
Segment by Type	Bronchodilators PDE-4 Inhibitors Steroids Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Novartis, Merck, Abbott, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer, Mylan, Allergan, Cipla, Akorn
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Obstructive Pulmonary Disease Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Obstructive Pulmonary Disease Treatment Drug Market report?

Ans: The main players in the Chronic Obstructive Pulmonary Disease Treatment Drug Market are GSK, Novartis, Merck, Abbott, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer, Mylan, Allergan, Cipla, Akorn

What are the Application segmentation covered in the Chronic Obstructive Pulmonary Disease Treatment Drug Market report?

Ans: The Applications covered in the Chronic Obstructive Pulmonary Disease Treatment Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Chronic Obstructive Pulmonary Disease Treatment Drug Market report?

Ans: The Types covered in the Chronic Obstructive Pulmonary Disease Treatment Drug Market report are Bronchodilators, PDE-4 Inhibitors, Steroids, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Bronchodilators

1.2.3 PDE-4 Inhibitors

1.2.4 Steroids

1.2.5 Others

1.3 Market by Application

1.3.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Perspective (2020-2031)

2.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Growth Trends by Region

2.2.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chronic Obstructive Pulmonary Disease Treatment Drug Historic Market Size by Region (2020-2025)

2.2.3 Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Region (2026-2031)

2.3 Chronic Obstructive Pulmonary Disease Treatment Drug Market Dynamics

2.3.1 Chronic Obstructive Pulmonary Disease Treatment Drug Industry Trends

2.3.2 Chronic Obstructive Pulmonary Disease Treatment Drug Market Drivers

2.3.3 Chronic Obstructive Pulmonary Disease Treatment Drug Market Challenges

2.3.4 Chronic Obstructive Pulmonary Disease Treatment Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chronic Obstructive Pulmonary Disease Treatment Drug Players by Revenue

3.1.1 Global Top Chronic Obstructive Pulmonary Disease Treatment Drug Players by Revenue (2020-2025)

3.1.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share by Players (2020-2025)

3.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chronic Obstructive Pulmonary Disease Treatment Drug Revenue

3.4 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Concentration Ratio

3.4.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in 2024

3.5 Global Key Players of Chronic Obstructive Pulmonary Disease Treatment Drug Head office and Area Served

3.6 Global Key Players of Chronic Obstructive Pulmonary Disease Treatment Drug, Product and Application

3.7 Global Key Players of Chronic Obstructive Pulmonary Disease Treatment Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Obstructive Pulmonary Disease Treatment Drug Breakdown Data by Type

4.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Historic Market Size by Type (2020-2025)

4.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Type (2026-2031)

5 Chronic Obstructive Pulmonary Disease Treatment Drug Breakdown Data by Application

5.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Historic Market Size by Application (2020-2025)

5.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (2020-2031)

6.2 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2020-2025)

6.4 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (2020-2031)

7.2 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2020-2025)

7.4 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (2020-2031)

8.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (2020-2031)

9.2 Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2020-2025)

9.4 Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (2020-2031)

10.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.1.4 GSK Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.1.5 GSK Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.2.4 Novartis Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.3.4 Merck Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.3.5 Merck Recent Development

11.4 Abbott

11.4.1 Abbott Company Details

11.4.2 Abbott Business Overview

11.4.3 Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.4.4 Abbott Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.4.5 Abbott Recent Development

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Details

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.5.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.5.5 Boehringer Ingelheim Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.6.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Roche

11.7.1 Roche Company Details

11.7.2 Roche Business Overview

11.7.3 Roche Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.7.4 Roche Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.7.5 Roche Recent Development

11.8 Teva

11.8.1 Teva Company Details

11.8.2 Teva Business Overview

11.8.3 Teva Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.8.4 Teva Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.8.5 Teva Recent Development

11.9 Vectura

11.9.1 Vectura Company Details

11.9.2 Vectura Business Overview

11.9.3 Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.9.4 Vectura Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.9.5 Vectura Recent Development

11.10 Pfizer

11.10.1 Pfizer Company Details

11.10.2 Pfizer Business Overview

11.10.3 Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.10.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.10.5 Pfizer Recent Development

11.11 Mylan

11.11.1 Mylan Company Details

11.11.2 Mylan Business Overview

11.11.3 Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.11.4 Mylan Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.11.5 Mylan Recent Development

11.12 Allergan

11.12.1 Allergan Company Details

11.12.2 Allergan Business Overview

11.12.3 Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.12.4 Allergan Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.12.5 Allergan Recent Development

11.13 Cipla

11.13.1 Cipla Company Details

11.13.2 Cipla Business Overview

11.13.3 Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.13.4 Cipla Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.13.5 Cipla Recent Development

11.14 Akorn

11.14.1 Akorn Company Details

11.14.2 Akorn Business Overview

11.14.3 Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Introduction

11.14.4 Akorn Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

11.14.5 Akorn Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Bronchodilators

Table 3. Key Players of PDE-4 Inhibitors

Table 4. Key Players of Steroids

Table 5. Key Players of Others

Table 6. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Region (2020-2025)

Table 10. Global Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Region (2026-2031)

Table 12. Chronic Obstructive Pulmonary Disease Treatment Drug Market Trends

Table 13. Chronic Obstructive Pulmonary Disease Treatment Drug Market Drivers

Table 14. Chronic Obstructive Pulmonary Disease Treatment Drug Market Challenges

Table 15. Chronic Obstructive Pulmonary Disease Treatment Drug Market Restraints

Table 16. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Players (2020-2025)

Table 18. Global Top Chronic Obstructive Pulmonary Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug as of 2024)

Table 19. Ranking of Global Top Chronic Obstructive Pulmonary Disease Treatment Drug Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Chronic Obstructive Pulmonary Disease Treatment Drug, Headquarters and Area Served

Table 22. Global Key Players of Chronic Obstructive Pulmonary Disease Treatment Drug, Product and Application

Table 23. Global Key Players of Chronic Obstructive Pulmonary Disease Treatment Drug, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share by Type (2020-2025)

Table 27. Global Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share by Type (2026-2031)

Table 29. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share by Application (2020-2025)

Table 31. Global Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share by Application (2026-2031)

Table 33. North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 48. GSK Company Details

Table 49. GSK Business Overview

Table 50. GSK Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 51. GSK Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 52. GSK Recent Development

Table 53. Novartis Company Details

Table 54. Novartis Business Overview

Table 55. Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 56. Novartis Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 57. Novartis Recent Development

Table 58. Merck Company Details

Table 59. Merck Business Overview

Table 60. Merck Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 61. Merck Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 62. Merck Recent Development

Table 63. Abbott Company Details

Table 64. Abbott Business Overview

Table 65. Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 66. Abbott Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 67. Abbott Recent Development

Table 68. Boehringer Ingelheim Company Details

Table 69. Boehringer Ingelheim Business Overview

Table 70. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 71. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 72. Boehringer Ingelheim Recent Development

Table 73. AstraZeneca Company Details

Table 74. AstraZeneca Business Overview

Table 75. AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 76. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 77. AstraZeneca Recent Development

Table 78. Roche Company Details

Table 79. Roche Business Overview

Table 80. Roche Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 81. Roche Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 82. Roche Recent Development

Table 83. Teva Company Details

Table 84. Teva Business Overview

Table 85. Teva Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 86. Teva Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 87. Teva Recent Development

Table 88. Vectura Company Details

Table 89. Vectura Business Overview

Table 90. Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 91. Vectura Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 92. Vectura Recent Development

Table 93. Pfizer Company Details

Table 94. Pfizer Business Overview

Table 95. Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 96. Pfizer Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 97. Pfizer Recent Development

Table 98. Mylan Company Details

Table 99. Mylan Business Overview

Table 100. Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 101. Mylan Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 102. Mylan Recent Development

Table 103. Allergan Company Details

Table 104. Allergan Business Overview

Table 105. Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 106. Allergan Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 107. Allergan Recent Development

Table 108. Cipla Company Details

Table 109. Cipla Business Overview

Table 110. Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 111. Cipla Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 112. Cipla Recent Development

Table 113. Akorn Company Details

Table 114. Akorn Business Overview

Table 115. Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Product

Table 116. Akorn Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025) & (US$ Million)

Table 117. Akorn Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Chronic Obstructive Pulmonary Disease Treatment Drug Picture

Figure 2. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Type: 2024 VS 2031

Figure 4. Bronchodilators Features

Figure 5. PDE-4 Inhibitors Features

Figure 6. Steroids Features

Figure 7. Others Features

Figure 8. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Clinic Case Studies

Figure 12. Others Case Studies

Figure 13. Chronic Obstructive Pulmonary Disease Treatment Drug Report Years Considered

Figure 14. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Players in 2024

Figure 18. Global Top Chronic Obstructive Pulmonary Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in 2024

Figure 20. North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Country (2020-2031)

Figure 22. United States Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Country (2020-2031)

Figure 26. Germany Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Region (2020-2031)

Figure 34. China Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Country (2020-2031)

Figure 42. Mexico Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Country (2020-2031)

Figure 46. Turkey Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 51. Merck Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 52. Abbott Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 53. Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 54. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 55. Roche Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 56. Teva Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 57. Vectura Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 58. Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 59. Mylan Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 60. Allergan Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 61. Cipla Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 62. Akorn Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Chronic Obstructive Pulmonary Disease Clinical Therapeutics Market Research Report 2025

Global Emphysema Drug Market Research Report 2025

Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Aerosol Bronchodilator Market Research Report 2025

Global Aerosol Therapy Device Market Research Report 2025

Lung Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Obstructive Sleep Apnea Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Asthma and COPD Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Idiopathic Pulmonary Fibrosis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bronchitis Treatment Drug Market Research Report 2025

Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Obstructive Pulmonary Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-39V14400

Wed May 14 00:00:00 UTC 2025

Add to Cart

Global Non-Invasive Respiratory Monitoring Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39L14149

Wed May 14 00:00:00 UTC 2025

Add to Cart

Global Soft Tissue Fixation Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24Y13844

Wed May 14 00:00:00 UTC 2025

Add to Cart

Global Hepatitis B and C Detection Kits Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32N13927

Wed May 14 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-39W12851

Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Research Report 2025

FEATURED COMPANIES

Chronic Obstructive Pulmonary Disease Treatment Drug Market Size

Chronic Obstructive Pulmonary Disease Treatment Drug Market

Scope of Chronic Obstructive Pulmonary Disease Treatment Drug Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Chronic Obstructive Pulmonary Disease Treatment Drug Market report?

What are the Application segmentation covered in the Chronic Obstructive Pulmonary Disease Treatment Drug Market report?

What are the Type segmentation covered in the Chronic Obstructive Pulmonary Disease Treatment Drug Market report?

FEATURED COMPANIES

RELATED REPORTS